Drugmakers Play The Patent Game To Lock In Prices, Block Competitors

Drugmakers Play The Patent Game To Lock In Prices, Block Competitors

Drugmakers Play The Patent Game To Lock In Prices, Block Competitors

Pharmaceutical companies like Purdue Pharma, maker of OxyContin, often win patents for incremental changes with debatable value. Now there’s a twist involving an opioid addiction treatment.

Read More…



Product Review